Now showing items 1-2 of 2

  • A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis 

    Rovira, Àlex; Nos, Carlos; Montalbán, Xavier; Sastre-Garriga, Jaume; Tintoré, Maria del Mar; Brieva, Luis; Aymerich Martínez, Francisco Javier; Río, Jordi; Porcel, Joana; Borrás, Cecilia (2009-10)
    Article
    Restricted access - publisher's policy
    Inflammation and neurodegeneration may have differential impacts on disease evolution in the different forms of multiple sclerosis. However, a beneficial effect of immunomodulatory drugs should not be ruled out in primary ...
  • Measures in the first year of therapy predict the response to interferon beta in MS 

    Montalbán, Xavier; Aymerich Martínez, Francisco Javier; Río, Jordi; Castillo, J.; Rovira, Àlex; Tintoré, Maria del Mar; Sastre-Garriga, Jaume; Horga, Alex; Nos, Carlos; Comabella, Manuel (2009-07)
    Article
    Restricted access - publisher's policy
    Several criteria for treatment response to interferon beta (IFNβ) have been proposed, although there is no consensus among different investigators. Hence, the aim of this study was to investigate magnetic resonance imaging ...